Director Declaration

Released : 17 Mar 2017 15:17

RNS Number : 8560Z
Dechra Pharmaceuticals PLC
17 March 2017




17 March 2017


Dechra® Pharmaceuticals PLC

("Dechra" or "the Company") 

Director's Declaration




In accordance with Listing Rule 9.6.14(2) Dechra announces that Ishbel Macpherson, Non-Executive Director of Dechra, is to be appointed as a

Non-Executive Director of Fidessa group plc with effect from 1 May 2017.




For further information:


Suzana Cross, Company Secretary  and General Counsel 

Telephone number: 01606 814730



About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit:



Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.


This information is provided by RNS
The company news service from the London Stock Exchange